SEVERAL ASPECTS OF DILTIAZEM AND ORGANIC NITRATES USAGE IN VARIOUS SEVERITY STABLE ANGINA PATIENTS
https://doi.org/10.15829/1728-8800-2014-2-18-23
Abstract
Aim. To estimate the effectiveness of Diltiazem (Dlt) and its combination with nitrates in patients with ischemic heart disease (CHD) and arterial hypertension (AH) according to exercise tolerance by functional class (FC) of stable angina (StA).
Material and methods. 30 CHD male patients at the age of 58,8±7,5 with StA II FC (n=11), III FC (n=19) and 1–2 stage AH were included into open randomized placebo-controlled study. Drug therapy: Dlt 90–180 mg bid, isosorbide 5-mononitrate 50 mg qd, trinitrolong 2 mg bid or tid. Effectiveness of the regular drug intake was controlled by repeated exercise tolerance tests (ETT) by treadmill with the value of threshold effort time (ThT). Total duration of treatment was 4 weeks.
Results. At the beginning the ThT was 249,8±23,4 s for III FC and 368,6±14,4 s for II FC patients (p=0,0001). One dose of Dlt increased ThT in 5 hours to 387,3±37,5 s and 533,7±20,3 s in both groups, respectively (p=0,001), with the difference between groups being held. During regular Dlt intake the ThT in III FC angina patients reached 441,1±26,8 s, but in II FC patients in has not changed: 526,1±22,0 s. Additional nitrate intake to III FC group led to even more increase of ThT; in II FC patients there was no improvement. Combination therapy by Dlt and nitrates has not led to differences between III and II FC groups by achieved exercise tolerance. Hemodynamic parameters in both groups has not differ.
Conclusion. For patients with III FC stable angina it is recommended to prescribe Dlt with nitrates because of additional effectiveness of combination that might be linked to the influence on cardiac hemodynamics and to improvement of myocardium metabolism. In II FC stable angina Dlt alone reaches its maximum antiischemic effect so the addition of nitrates is not helpful.
About the Authors
E. K. ButinaRussian Federation
E. V. Bochkareva
Russian Federation
N. A. Pozdnyakova
Russian Federation
References
1. Leal J, Luenqo-Fernandez R, Gray A, et al Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27: 1610–9.
2. Fox K, Garcia MA, Ardissino D. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341–81.
3. Diagnosis and treatment of stable angina. Russian recommendations. Developed by the Committee of Experts of the Russian Scientific society of Cardiology. Cardiovascular Therapy and Prevention 2008; 7 (6), suppl. 4. Russian (Диагностика и лечение стабильной стенокардии. Российские рекомендации. Разработаны Комитетом экспертов Всероссийского научного общества кардиологов. Кардиоваскулярная терапия и профилактика 2008; 7 (6), приложение 4).
4. Oganov RG, Lepahin VK, Fitilev SB, et al. Features of diagnosis and treatment of stable angina in the Russian Federation (the international study ATP-Angina Treatment Pattern). Cardiology 2003; 5: 9–15. Russian (Оганов Р. Г., Лепахин В. К., Фитилев С. Б. и др. Особенности диагностики и терапии стабильной стенокардии в Российской Федерации (международное исследование ATP-Angina Treatment Pattern). Кардиология 2003; 5: 9–15).
5. Barrios V. Diltiazem in the treatment of hypertension and ischemic heart disease. Expert Rev Cardiovasc Ther. 2011; 9 (11): 1375–82
6. Deanfield JE, Detry J-M, Sellier P, et al. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. JACC 2002; 40: 917–25.
7. Hansson L, Hedner T, Lund-Johansen P, et al. Randomised trial of effect of calcium antagonists compared with diuretics and blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000; 356: 359–65.
8. Pozdnjakova NA, Kokurina EV, Bochkareva EV, et al. Pharmacodynamic properties diltiazem monotherapy and in combination with nitrates in patients with stable angina and hypertension 1–2 degrees. Prev Medicine 2010; 13 (4): 33–8. (Позднякова Н. А., Кокурина Е. В., Бочкарева Е. В. и др. Фармакодинамические свойства дилтиазема при монотерапии и в комбинации с нитратами у больных стенокардией и артериальной гипертонией 1–2 степени. Проф медицина 2010; 13 (4): 33–8).
9. Idrisova EM, Stepacheva TA, Borovkova NV, et al. Diltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension. Klin Med 2004; 82 (2): 42–6.
10. Semencov DP, Kutishenko NP, Alimova EV, Marcevich SJu. The efficacy of different calcium antagonists prolonged action in the treatment of stable angina. Klin gerontology 2000; 5–6: 46–51. Russian (Семенцов Д. П., Кутишенко Н. П., Алимова Е. В., Марцевич С. Ю. Эффективность различных антагонистов кальция пролонгированного действия в лечении стабильной стенокардии напряжения. Клин геронтология 2000; 5–6: 46–51).
11. Joyal M, Cremer KF, Pieper JA, et al. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease. Am J Cardiol 1985; 56 (7): 413–7.
12. Meluzín J, Novák M, Koukalová H. Comparison of the effects of nifedipine and diltiazem in patients with stable angina pectoris of various severity and pathomorphology of the coronary arteries. Vnitr Lek 1991; 37 (5): 441–8.
13. Jackson G. Stable angina: maximal medical therapy is not same as optimal medical therapy. Int J Clin Pract 2000; 54 (6): 351.
14. Bochkareva EV, Kokurina EV, Voronina VP, et al. Silent myocardial ischemia at different levels of blood pressure in patients with angina pectoris (J-shaped relationship). Cardiology 2005; 5: 34–7. Russian (Бочкарева Е. В., Кокурина Е. В., Воронина В. П. и др. Безболевая ишемия миокарда при различных уровнях артериального давления у больных стенокардией напряжения (J-образная зависимость). Кардиология 2005; 5: 34–7).
Review
For citations:
Butina E.K., Bochkareva E.V., Pozdnyakova N.A. SEVERAL ASPECTS OF DILTIAZEM AND ORGANIC NITRATES USAGE IN VARIOUS SEVERITY STABLE ANGINA PATIENTS. Cardiovascular Therapy and Prevention. 2014;13(2):18-23. (In Russ.) https://doi.org/10.15829/1728-8800-2014-2-18-23